Kirsten Gormly
Adelaide Medical School
Faculty of Health and Medical Sciences
Clinical radiologist with subspecilaty expertise in oncology and pelvic imaging. Clinical Senior Lecturer - The University of Adelaide, Past chair & current executive member - Abdominal Radiology Group of Australia & New Zealand, Corresponding Fellow - European Society of Gastrointestinal and Abdominal Radiology, Fellow - International Cancer Imaging Society, Member - Society of Abdomial Radiology (USA) Anorectal Disease Focused Panel.
Research interests include rectal MRI, prostate cancer, Dual energy CT, improvements in radiology education and reporting, with national and international colaborations.
Educational contributions predominantly involve national and international radiologist and non radiology meetings and workshops. Contributions to face to face teaching at The University of Adelaide in MS1 & MS4 and virtual lectures for MS3.
My primary research is focused on gastrointestinal and urological conditions, in particular rectal and prostate cancer. I am involved in imaging based research as well as collaborations which assess imaging as part of disease assessment and management.
I also focus on assessing the uptake and use of guidelines for technical quality and reporting in oncological imaging. Poor image quality reduces the ability to report accurately and failure to use standardised guidelines impedes the ability to compare international research findings accurately.
Assessing new imaging technologies in oncological and abdominal imaging, such as Dual energy CT, Photon counting CT, high gradient MRI systems and AI assisted MRI sequences is an additional area of research activity.
-
Appointments
Date Position Institution name 2020 - ongoing Clinical Senior Lecturer The University of Adelaide 2009 - ongoing Radiologist Jones Radiology -
Education
Date Institution name Country Title University of Adelaide Australia MBBS -
Postgraduate Training
Date Title Institution Country FRANZCR Royal Australian and New Zealand College of Radiologists Australia -
Research Interests
-
Journals
Year Citation 2025 Brown, K. J., Agarwal, A., & Gormly, K. L. (2025). Use and Perceptions of Oncology CT Structured Reports in Australia and New Zealand. Journal of Medical Imaging and Radiation Oncology, 7 pages.
2025 Gormly, K. L. (2025). Improving radiology reporting locally and globally: who, how and why?. British Journal of Radiology, 98(1167), 330-335.
2025 Nougaret, S., Gormly, K., Lambregts, D. M. J., Reinhold, C., Goh, V., Korngold, E., . . . Brown, G. (2025). MRI of the Rectum: A Decade into DISTANCE, Moving to DISTANCED. Radiology, 314(1), 19 pages.
Scopus1 Europe PMC12024 Jain, A., Gormly, K. L., Glyn, T., Sammour, T., Koay, E. J., Oar, A., . . . Vatandoust, S. (2024). Management of rectal cancer in the era of total neoadjuvant therapy and watch and wait: A multidisciplinary team discussion at the Australasian Gastro‐Intestinal Trials Group (AGITG) Annual Scientific Meeting 2022. Asia-Pacific Journal of Clinical Oncology, 20(1), 71-80.
Scopus22024 O'Callaghan, M., Bulamu, N., Gormly, K., & Jay, A. (2024). Re: Prevalence of MRI Lesions in Men Responding to a GP-led Invitation for a Prostate Health Check: A Prospective Cohort Study. European Urology, 85(4), 395.
Europe PMC42023 Nougaret, S., Rousset, P., Lambregts, D. M. J., Maas, M., Gormly, K., Lucidarme, O., . . . Hoeffel, C. (2023). MRI restaging of rectal cancer: The RAC (Response–Anal canal–CRM) analysis joint consensus guidelines of the GRERCAR and GRECCAR groups. Diagnostic and Interventional Imaging, 104(7-8), 311-322.
Scopus5 Europe PMC32023 Gormly, K. L. (2023). Anal cancer MRI: DWI assists response assessment for squamous cell carcinoma, but achieving widespread high-quality scans remains challenging. European Radiology, 33(11), 7573-7574.
Scopus12023 Seah, H. M., Choi, H. C., Bajic, N., Oakden-Rayner, L., & Gormly, K. L. (2023). Assessment of a single-pass venous phase CT chest, abdomen and pelvis and dual-energy CT in general oncology outpatients. Journal of Medical Imaging and Radiation Oncology, 67(4), 349-356.
Scopus32023 Roy, A., Shepherdson, M., Gormly, K., Byrne, S., Pedersen, S., Price, T., . . . Symonds, E. L. (2023). Circulating tumour DNA and MRI circumferential resection margin are key prognostic indicators for survival in rectal cancer. ESMO Gastrointestinal Oncology, 2, 100013-1-100013-7.
2022 Vatandoust, S., Wattchow, D., Sposato, L., Michael, M. Z., Leung, J., Gormly, K., . . . Karapetis, C. S. (2022). A longitudinal cohort study of watch and wait in complete clinical responders after chemo-radiotherapy for localised rectal cancer: study protocol. BMC Cancer, 22(1), 13 pages.
Scopus7 WoS2 Europe PMC52022 Nougaret, S., Rousset, P., Gormly, K., Lucidarme, O., Brunelle, S., Milot, L., . . . Hoeffel, C. (2022). Structured and shared MRI staging lexicon and report of rectal cancer: A consensus proposal by the French Radiology Group (GRERCAR) and Surgical Group (GRECCAR) for rectal cancer. Diagnostic and Interventional Imaging, 103(3), 127-141.
2022 Croft, M., Lim, W., Lavender, N., & Gormly, K. (2022). Optimising CT‐chest protocols and the added value of venous‐phase contrast timing; Observational case‐control. Journal of Medical Imaging and Radiation Oncology, 66(6), 768-775.
Scopus4 WoS2 Europe PMC32021 Gormly, K. (2021). Rectal MRI: the importance of high resolution T2 technique. Abdominal Radiology, 46(9), 4090-4095.
Scopus10 WoS4 Europe PMC72021 Gormly, K. L. (2021). High-resolution t2-weighted mri to evaluate rectal cancer: Why variations matter. Korean Journal of Radiology, 22(9), 1475-1480.
Scopus8 WoS2 Europe PMC62021 Shepherdson, M., Symonds, E. L., Byrne, S., Gormly, K., Karapetis, C. S., Vatandoust, S., . . . Roy, A. C. (2021). Circulating tumor DNA and circumferential resection margin as key prognostic indicators for survival in rectal cancer.. Journal of Clinical Oncology, 39(15_suppl), 3579.
2019 Raeside, M., Low, A., Cohen, P., Sutherland, P., & Gormly, K. (2019). Prostate MRI evolution in clinical practice: Audit of tumour detection and staging versus prostatectomy with staged introduction of multiparametric MRI and Prostate Imaging Reporting and Data System v2 reporting. Journal of Medical Imaging and Radiation Oncology, 63(4), 487-494.
Scopus5 WoS2 Europe PMC32019 Jameson, M. B., Gormly, K., Espinoza, D., Hague, W., Asghari, G., Jeffery, G. M., . . . Ackland, S. P. (2019). SPAR - A randomised, placebo-controlled phase II trial of simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer: An AGITG clinical trial. BMC Cancer, 19(1), 12 pages.
Scopus15 WoS12 Europe PMC132018 Hoffmann, R., Logan, C., O Callaghan, M., Gormly, K., Chan, K., & Foreman, D. (2018). Does the Prostate Imaging-Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multiparametric magnetic resonance imaging (mpMRI)?. International Urology and Nephrology, 50(1), 13-19.
Scopus11 WoS9 Europe PMC92017 Roy, A. C., Wattchow, D., Astill, D., Singh, S., Pendlebury, S., Gormly, K., & Segelov, E. (2017). Uncommon Anal Neoplasms. Surgical Oncology Clinics of North America, 26(1), 143-161.
2016 Gormly, K. L., Coscia, C., Wells, T., Tebbutt, N., Harvey, J. A., Wilson, K., . . . Price, T. (2016). MRI rectal cancer in Australia and New Zealand: an audit from the PETACC-6 trial. Journal of Medical Imaging and Radiation Oncology, 60(5), 607-615.
Scopus7 WoS4 Europe PMC62016 Raeside, M. C., Gormly, K., Neuhaus, S. J., Kotasek, D., & James, C. (2016). Primary pericardial mesothelioma presenting as multiple pericardial masses on CT. BJR CASE REPORTS, 2(1), 4 pages.
WoS3 Europe PMC22016 Siddiqui, M. R. S., Gormly, K. L., Bhoday, J., Balyansikova, S., Battersby, N. J., Chand, M., . . . Brown, G. (2016). Interobserver agreement of radiologists assessing the response of rectal cancers to preoperative chemoradiation using the MRI tumour regression grading (mrTRG). Clinical Radiology, 71(9), 854-862.
Scopus66 WoS49 Europe PMC482015 Gormly, K. L. M., Coscia, C., Wells, T., Tebbutt, N., Harvey, J. A., Wilson, K., . . . Price, T. (2015). MRI rectal cancer in Australia and New Zealand: an audit from the PETACC-6 trial. Cancer Imaging, 15(S1).
2009 Gormly, K. L. M. (2009). Standardised tumour, node and metastasis reporting of oncology CT scans. JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 53(4), 345-352.
WoS4 Europe PMC32008 Smith, G. E. C., & Gormly, K. L. M. (2008). Magnetic Resonance Imaging in the staging of cervical carcinoma: A pictorial review. Journal of Medical Imaging and Radiation Oncology, 52(5), 427-433.
Scopus3 WoS3 Europe PMC32004 Gormly, K., & Glastonbury, C. M. (2004). Calcified nodal metastasis from squamous cell carcinoma of the head and neck. Australasian Radiology, 48(2), 240-242.
1996 Gormly, K. L., & Langlois, S. L. P. (1996). Assessment of an online radiology reporting system. Australasian Radiology, 40(4), 408-411.
-
Books
-
Book Chapters
Year Citation 2007 Hricak, H., Husband, J., Panicek, D. M., Akin, O., Gormly, K. L., Grewal, R. K., . . . Daniel, E. (2007). Contributors. In Oncologic Imaging (pp. v-viii). Elsevier.
DOI -
Conference Papers
Year Citation 2024 Brown, K., Agarwal, A., & Gormly, K. (2024). Errors in oncology CT : Analysis of a discrepancy database over 8 years. In Abstracts of the ICIS SGCR-WIRES 2024, held jointly with the 23rd International Cancer Imaging Society Annual Conference as published in Cancer Imaging Vol. 24 (pp. P22-14). Singapore: BMC.
DOI2024 Chai, N., Malalagama, G., Jameson, M., Ackland, S., & Gormly, K. (2024). SPAR Rectal MRI Technique Sub-study, with Technique and Reporting Survey in Australia and New Zealand. In ESGAR 2024 Book of Abstracts as published in Insights into Imaging Vol. 15 (pp. 30). Gothenberg, Sweden: SpringerOpen.
DOI2022 Jameson, M. B., Gormly, K., Espinoza, D., Hague, W., Jeffery, G. M., Price, T. J., . . . Ackland, S. P. (2022). SPAR: A randomized placebo-controlled phase 2 trial of simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer: An AGITG clinical trial. In JOURNAL OF CLINICAL ONCOLOGY Vol. 40 (pp. 1 page). ELECTR NETWORK: LIPPINCOTT WILLIAMS & WILKINS. 2021 Gormly, K., Espinoza, D., Hague, W., Jeffrey, M., Price, T., Karapetis, C., . . . Ackland, S. (2021). SPAR: Randomised phase II study of chemoradiation with or without simvastatin as preoperative treatment for rectal cancer (an AGITG trial). In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY Vol. 17 (pp. 36). WILEY. 2016 Siddiqui, M. R. S., Bhoday, J., Balyansikova, S., Battersby, N. J., Gormly, K. L., Rao, S., . . . Brown, G. (2016). Inter-observer agreement of radiologists assessing the response of rectal cancers after chemoradiation therapy according to MRI tumour regression grading (mrTRG). In BRITISH JOURNAL OF SURGERY Vol. 103 (pp. 17). Royal Coll Surg England, London, ENGLAND: WILEY-BLACKWELL. - Dwyer, A., Walls, A., Gormly, K., Raeside, M., & Withey, S. (2024, May 4). Optimisation and implementation of high b-value DWI using 200mT/m gradient system for clinical prostate MRI.. In ISMRM Annual Meeting. ISMRM.
DOI
SPAR: A randomised placebo-controlled phase 2 trial of simvastatin with preoperative chemoradiation for rectal cancer’. M Jameson, S Ackland, M Pearse , S Ngan, F Frizelle, A Stevenson, K Gormly. M Arendse. 2018
- Health Research Council on NZ (HRC) $NZ 1,399,053
- Cancer Society New Zealand $NZ 149,290,
RENO: Prospective Study of ‘Watch and Wait’ Strategy in patients with Rectal Cancer who have developed a Clinical Complete Response with concurrent Chemo-radiotherapy. C Karapetis, D Wattchow, S Vatandoust, L Sposato. CI. 2018
- AGITG innovation grant $200,000
Evaluation of blood-based screening tests for colorectal neoplasia; from biomarker candidates to accurate and acceptable tests. E Symonds, GP Young, M Michael, ..... A Roy, C Karapetis, K Gormly. 2020
- AGITG innovation grant $200,000
PETACC 6 Trial: Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer. TJ Price, J Harvey, N Tebbutt, J Zalcberg, J Simes, G Hruby
- 2013. Cancer Australia + Cancer Council NSW 123,331 + 19,624.
- 2009-11. Cancer Australia 477,800
Contributions to the new BMS / MD Medical Course include;
MS1 & 2 imaging content
MS3 lectures:
- Imaging in Prostate cancer
- Imaging in Testicular cancer
- Imaging in Ovarian Cancer
- Imaging in Uterine cancer
- Imaging in Cervix cancer
Planned 4th year MD - face to face session; General Surgical Imaging
Extensive vocational lecturing to radiologists and other medical and allied health groups in national and international forums, including conferences and workshops.
Connect With Me
External Profiles
